On March 28, EverBridge Group signed an agreement at the 2025 "Invest in Beijing" Summit hosted by the Beijing Municipal Government, officially marking the launch of its medical headquarters project in Daxing District, Beijing.

During the project’s implementation, the district’s "full-lifecycle service chain" provided meticulous support, allowing the group to fully appreciate the immense value of establishing its presence in Beijing. The city’s continuous efforts to optimize its business environment, coupled with seamless collaboration between municipal agencies and district-level industrial bases, ensured a smooth entry process for the group. This strong institutional backing provides a solid foundation for EverBridge Group ’s sustained innovation and growth.

Moreover, Beijing’s unique medical innovation ecosystem—powered by its abundance of research institutes and top-tier medical institutions—has successfully incubated numerous outstanding translational medical achievements. Under the careful coordination of preferential incentive programs and industrial innovation alliances, these breakthroughs have achieved a seamless transition from scientific research to commercialization, creating fertile ground for pioneering advancements in the healthcare sector.